These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19997085)

  • 1. ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease.
    Stone DJ; Molony C; Suver C; Schadt EE; Potter WZ
    Pharmacogenomics J; 2010 Jun; 10(3):161-4. PubMed ID: 19997085
    [No Abstract]   [Full Text] [Related]  

  • 2. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele predicted accelerated rate of cognitive decline in Alzheimer's disease.
    Burke D
    West J Med; 1999 Jul; 171(1):23. PubMed ID: 10483340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Frequency of the APOE-4 allele in Alzheimer's disease and its variation with age in Asturias (Spain)].
    Alvarez V; Alvarez R; Peña J; Lahoz CH; Martínez C; Menéndez-Guisasola L; Salas-Puig J; Morís G; Uría D; Menes BB; Ribacoba R; Vidal JA; Coto E
    Med Clin (Barc); 1999 Oct; 113(12):441-3. PubMed ID: 10570509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apolipoprotein E polymorphism and Alzheimer disease].
    van der Weide J; Steijns LS; Teepen JL; Noback WJ; Klaverwijden G
    Tijdschr Gerontol Geriatr; 1996 Apr; 27(2):73-7. PubMed ID: 8669075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
    Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
    Lai MK; Tsang SW; Garcia-Alloza M; Minger SL; Nicoll JA; Esiri MM; Wong PT; Chen CP; Ramírez MJ; Francis PT
    Neurobiol Dis; 2006 Jun; 22(3):555-61. PubMed ID: 16473016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
    Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease.
    Kowalska A; Florczak J; Pruchnik-Wolińska D; Kraszewski A; Wender M
    Arch Immunol Ther Exp (Warsz); 1998; 46(3):177-81. PubMed ID: 9704150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative.
    Bennett C; Crawford F; Osborne A; Diaz P; Hoyne J; Lopez R; Roques P; Duara R; Rossor M; Mullan M
    Am J Med Genet; 1995 Feb; 60(1):1-6. PubMed ID: 7485228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE epsilon4 is a high-risk factor for Alzheimer's disease in the Mongolian population.
    Huriletemuer ; Wang B; Wang J; Wang G; Zhang C; Zhao S; Zhou S; Ma X; Wang de S
    J Neurol Sci; 2010 Jan; 288(1-2):167-9. PubMed ID: 19819468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of genetic variation of apolipoprotein E in Alzheimer's disease].
    Martínez Lage JM
    Med Clin (Barc); 1999 Oct; 113(12):449-51. PubMed ID: 10570512
    [No Abstract]   [Full Text] [Related]  

  • 16. Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease.
    Lucotte G; Aouizérate A; Gérard N; Turpin JC; Landais P
    Am J Med Genet; 1995 Dec; 60(6):566-9. PubMed ID: 8825898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA; Hermann B; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.
    Osuntokun BO; Sahota A; Ogunniyi AO; Gureje O; Baiyewu O; Adeyinka A; Oluwole SO; Komolafe O; Hall KS; Unverzagt FW
    Ann Neurol; 1995 Sep; 38(3):463-5. PubMed ID: 7668835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of ApoE study in Thai elderly.
    Senanarong V; Harnphadungkit K; Lertrit P; Mitrpant C; Udompunthurak S; Limwong C; Prayoonwiwat N; Poungvarin N
    J Med Assoc Thai; 2001 Feb; 84(2):182-7. PubMed ID: 11336076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.